CA Stock MarketDetailed Quotes
AGN Algernon Pharmaceuticals Inc
- 0.125
- -0.005-3.85%
15min DelayMarket Closed Aug 9 15:59 ET
3.17MMarket Cap-3676P/E (TTM)
0.125High0.115Low64.30KVolume0.125Open0.130Pre Close7.61KTurnover0.20052wk High0.46%Turnover Ratio25.34MShares0.05052wk Low-0.034EPS TTM1.77MFloat Cap27.500Historical HighLossP/E (Static)14.14MShs Float0.050Historical Low-0.45EPS LYR7.69%Amplitude--Dividend TTM1.62P/B1Lot Size--Div YieldTTM
Algernon Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | (FY)Aug 31, 2022 | (Q4)Aug 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 40.37%609.52K | -65.42%76.28K | -89.25%74.17K | -91.12%125.09K | -91.12%125.09K | -50.25%434.23K | -87.84%220.59K | -74.43%689.7K | -41.58%1.41M | -41.58%1.41M |
| -Cash and cash equivalents | 40.37%609.52K | -65.42%76.28K | -89.25%74.17K | -91.12%125.09K | -91.12%125.09K | -50.25%434.23K | -87.84%220.59K | -74.43%689.7K | -41.58%1.41M | -41.58%1.41M |
| -Accrued interest receivable | -27.84%184 | 5.14%1.12K | 5.29%816 | 111.02%1.02K | 111.02%1.02K | -79.00%255 | -30.85%1.07K | -18.34%775 | -0.62%481 | -0.62%481 |
| Total current assets | 17.03%687K | -74.17%123.25K | -90.79%121.79K | -87.98%339.83K | -87.98%339.83K | -62.32%587.01K | -80.63%477.12K | -59.23%1.32M | -42.41%2.83M | -42.41%2.83M |
| Non current assets | ||||||||||
| -Goodwill | -39.98%3.18M | -28.30%3.8M | -28.20%3.8M | -27.77%3.8M | -27.77%3.8M | 0.11%5.29M | 0.76%5.3M | 1.48%5.29M | 1.65%5.26M | 1.65%5.26M |
| Regulatory assets | -87.11%9.2K | -66.46%31.04K | -93.28%14.38K | -85.57%96.06K | -85.57%96.06K | -86.00%71.32K | -80.69%92.56K | -33.83%213.96K | -71.00%665.53K | -71.00%665.53K |
| Total assets | -87.32%9.01K | -67.30%29.92K | -93.64%13.56K | -85.71%95.04K | -85.71%95.04K | -86.01%71.07K | 51.44%91.49K | 416.34%213.18K | -71.01%665.05K | -71.01%665.05K |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| -accounts payable | --1.76M | --3.18M | --2.87M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Total tax payable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Due to related parties current | --172.48K | --340.07K | --72.14K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other payable | -50.00%28.75K | -50.00%28.75K | -50.00%28.75K | 0.00%57.5K | 0.00%57.5K | 0.00%57.5K | 0.00%57.5K | 0.00%57.5K | 0.00%57.5K | 0.00%57.5K |
| Current liabilities | -20.02%1.93M | 43.67%3.52M | 31.34%2.94M | 8.09%2.72M | 8.09%2.72M | 79.16%2.41M | 69.83%2.45M | 258.02%2.24M | 146.12%2.52M | 146.12%2.52M |
| Non current liabilities | ||||||||||
| Total non current liabilities | -20.02%1.93M | 43.67%3.52M | 31.34%2.94M | 8.09%2.72M | 8.09%2.72M | 79.16%2.41M | 69.83%2.45M | 258.02%2.24M | 146.12%2.52M | 146.12%2.52M |
| Shareholders'equity | ||||||||||
| Share capital | 4.02%29.14M | 6.32%29.11M | 3.34%28.15M | 3.82%28.15M | 3.82%28.15M | 8.37%28.01M | 5.91%27.38M | 5.38%27.24M | 4.90%27.12M | 4.90%27.12M |
| -common stock | 4.02%29.14M | 6.32%29.11M | 3.34%28.15M | 3.82%28.15M | 3.82%28.15M | 8.37%28.01M | 5.91%27.38M | 5.38%27.24M | 4.90%27.12M | 4.90%27.12M |
| Gains losses not affecting retained earnings | -16.11%3.26M | -29.07%3.21M | -2.01%4.18M | 11.37%4.12M | 11.37%4.12M | 37.76%3.89M | -36.04%4.52M | -37.23%4.26M | -45.74%3.7M | -45.74%3.7M |
| Total equity | -36.55%3.89M | -34.48%3.95M | -40.79%3.95M | -48.49%4.19M | -48.49%4.19M | -11.12%6.14M | -22.46%6.03M | -21.65%6.67M | -19.70%8.14M | -19.70%8.14M |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg